HK1201271A1 - Kinase inhibitor polymorphs - Google Patents

Kinase inhibitor polymorphs Download PDF

Info

Publication number
HK1201271A1
HK1201271A1 HK15101873.3A HK15101873A HK1201271A1 HK 1201271 A1 HK1201271 A1 HK 1201271A1 HK 15101873 A HK15101873 A HK 15101873A HK 1201271 A1 HK1201271 A1 HK 1201271A1
Authority
HK
Hong Kong
Prior art keywords
kinase inhibitor
polymorphs
inhibitor polymorphs
kinase
inhibitor
Prior art date
Application number
HK15101873.3A
Other languages
English (en)
Chinese (zh)
Inventor
Martin Michael
Peter Worrall Christopher
Del Rio Gancedo Susanna
Ren Pingda
Original Assignee
Intellikine, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intellikine, Llc filed Critical Intellikine, Llc
Publication of HK1201271A1 publication Critical patent/HK1201271A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK15101873.3A 2011-11-11 2012-11-12 Kinase inhibitor polymorphs HK1201271A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161558962P 2011-11-11 2011-11-11
US61/558,962 2011-11-11
PCT/US2012/064729 WO2013071272A1 (en) 2011-11-11 2012-11-12 Kinase inhibitor polymorphs

Publications (1)

Publication Number Publication Date
HK1201271A1 true HK1201271A1 (en) 2015-08-28

Family

ID=48290672

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15101873.3A HK1201271A1 (en) 2011-11-11 2012-11-12 Kinase inhibitor polymorphs

Country Status (5)

Country Link
US (1) US9403820B2 (enExample)
EP (1) EP2776428A4 (enExample)
JP (1) JP6078076B2 (enExample)
HK (1) HK1201271A1 (enExample)
WO (1) WO2013071272A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2368941T3 (es) 2003-01-06 2011-11-23 Angiochem Inc. Angiopep-1, compuestos relacionados y utilizaciones correspondientes.
US9365634B2 (en) 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
JP5860698B2 (ja) 2008-04-18 2016-02-16 アンジオケム，インコーポレーテッド パクリタキセル、パクリタキセル類似体またはパクリタキセルコンジュゲートの医薬組成物ならびに関連する調製方法および使用方法
EP2346906A4 (en) 2008-10-15 2013-04-24 Angiochem Inc CONJUGATES FROM GLP-1 AGONISTS AND THEIR USE
JP5705118B2 (ja) 2008-10-15 2015-04-22 アンジオケム インコーポレーテッド 薬物送達のためのエトポシドおよびドキソルビシン複合体
JP5759379B2 (ja) 2008-12-05 2015-08-05 アンジオケム インコーポレーテッド ニューロテンシンまたはニューロテンシンアナログおよびその使用
WO2010069074A1 (en) 2008-12-17 2010-06-24 Universite Du Quebec A Montreal Membrane type-1 matrix metalloprotein inhibitors and uses thereof
EP2421562B1 (en) 2009-04-20 2019-03-13 Angiochem Inc. Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
RU2012103240A (ru) 2009-07-02 2013-08-10 Ангиокем Инк. Мультимерные пептидные конъюгаты и их применение
EP2792360A1 (en) 2013-04-18 2014-10-22 IP Gesellschaft für Management mbH (1aR,12bS)-8-cyclohexyl-11-fluoro-N-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,2b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide for use in treating HCV
JP2016536282A (ja) * 2013-10-03 2016-11-24 ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． ＰＩ３Ｋα阻害剤を使用する強化された治療レジメン
CA2989400A1 (en) 2015-06-15 2016-12-22 Angiochem Inc. Ang1005 for the treatment of leptomeningeal carcinomatosis
JP2018039755A (ja) * 2016-09-08 2018-03-15 大塚化学株式会社 ナトリウム２α−メチル−２β−（１，２，３−トリアゾール−１−イル）−メチルペナム−３α−カルボン酸１，１−ジオキシド一水和物結晶の製造方法
AU2021299348A1 (en) * 2020-07-02 2023-02-02 Artham Therapeutics Inc. Oral pharmaceutical composition and method for producing same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068378B1 (en) * 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
DE10050663A1 (de) * 2000-10-13 2002-04-18 Gruenenthal Gmbh Verwendung von substituierten Imidazo[1,2-a]pyridin-, -pyrimidin- und pyrazin-3-yl-amin-Derivaten zur Herstellung von Medikamenten zur NOS-Inhibierung
EP1546146A1 (en) 2003-06-03 2005-06-29 Teva Pharmaceutical Industries Limited POLYMORPHIC FORMS OF ZIPRASIDONE HCl AND PROCESSES FOR THEIR PREPARATION
EP1591625A1 (en) * 2004-04-30 2005-11-02 ALSTOM Technology Ltd Gas turbine blade shroud
BRPI0616722A2 (pt) * 2005-09-30 2012-12-25 Astrazeneca Ab composto ou um sal farmaceuticamente aceitÁvel ou um Éster hidrolisÁvel in vivo do mesmo, processo para preparar o mesmo, composiÇço farmacÊutica, uso de um composto ou um sal farmaceuticamente aceitÁvel ou um Éster hidrolisÁvel in vivo do mesmo, e, mÉtodos para produzir um efeito anti-proliferaÇço celular e um efeito inibidor cdk2, para tratar cÂncer, e para tratar doenÇas
AU2009204483B2 (en) 2008-01-04 2014-03-13 Intellikine, Llc Certain chemical entities, compositions and methods
US8193182B2 (en) * 2008-01-04 2012-06-05 Intellikine, Inc. Substituted isoquinolin-1(2H)-ones, and methods of use thereof
US8476431B2 (en) * 2008-11-03 2013-07-02 Itellikine LLC Benzoxazole kinase inhibitors and methods of use
GEP201706639B (en) * 2009-08-17 2017-03-27 Intellikine Llc Heterocyclic compounds and uses thereof

Also Published As

Publication number Publication date
JP2014533285A (ja) 2014-12-11
WO2013071272A1 (en) 2013-05-16
JP6078076B2 (ja) 2017-02-08
US20150005301A1 (en) 2015-01-01
US9403820B2 (en) 2016-08-02
EP2776428A4 (en) 2015-04-22
EP2776428A1 (en) 2014-09-17

Similar Documents

Publication Publication Date Title
ZA201401211B (en) Kinase inhibitor polymorphs
EP2723741B8 (en) Substituted imidazopyridinyl-aminopyridine compounds
EP2710018B8 (en) Macrocyclic compounds as protein kinase inhibitors
HUE048834T2 (hu) Kináz inhibitorok
HK1201271A1 (en) Kinase inhibitor polymorphs
ZA201404156B (en) Kinase inhibitors
IL228103A0 (en) Amino-quinolines as kinase inhibitors
IL229028A0 (en) Kinase inhibitors
EP2903618A4 (en) Rho kinase inhibitors
EP2552208A4 (en) IMIDAZOLYL-IMIDAZOLES AS KINASE INHIBITORS
IL228967B (en) Heterocyclic compounds as kinase inhibitors
EP2552214A4 (en) PYRAZOLYL-PYRIMIDINES AS KINASE INHIBITORS
EP2552211A4 (en) INDAZOLYL-PYRIMIDINE AS KINASEHEMMER
AP3597A (en) Imidazopyridazines as akt kinase inhibitors
ZA201404157B (en) Kinase inhibitors
AU2011904448A0 (en) Compounds
HK1192543A (en) Serine/threonine kinase inhibitors
AU2011100047A4 (en) Memoriade
AU2011100090A4 (en) Alcotagz
GB201009730D0 (en) Kinase inhibitor compounds
HK1194061A (en) Raf kinase inhibitors
HK1195057A (en) Protein kinase inhibitors
AU2012905703A0 (en) Polymorph
HK1187784A (en) Cathepsin c inhibitors
HK1193613A (en) Novel inhibitor compounds of phosphodiesterase type 10a